Filters

Latest News

2021-03-09 17:00:38

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential

9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & ...

Read More

2021-02-18 14:00:30

The AMR Action Fund announces its first non-industry investments, raising an additional US$140 million toward addressing antimicrobial resistance (AMR)

The AMR Action Fund, launched in July 2020, aims to bring 2 to 4 new ...

Read More

2021-02-18 14:00:21

The AMR Action Fund announces appointment of CEO, Henry B. Skinner, PhD

Dr. Skinner will help ensure the AMR Action Fund achieves its mission to bring two ...

Read More

2021-02-05 15:02:40

Patients, product development partnerships and private health sector representatives call for the rapid ratification of the African Medicines Agency Treaty to speed up timelines to vaccines and medicines approval

London / Geneva, 5 February 2021 – On the eve of the 34th African Union ...

Read More

2021-01-25 07:00:01

Biopharmaceutical global body kicks off 2021 with new CEO leadership line up

Geneva, 25 January 2021 –The biopharmaceutical global industry, represented by the International Federation of Pharmaceutical Manufacturers ...

Read More

2021-01-12 11:27:48

Speak Up Africa and IFPMA start their search for winners of the Africa Young Innovators for Health Award

The Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme ...

Read More

2020-12-08 12:45:58

Speak Up Africa and IFPMA launch the “Africa Young Innovators for Health Award” to fuel innovation and help advance promising healthcare solutions

The first edition of the “Africa Young Innovators for Health Award” aims to support entrepreneurs ...

Read More

Latest Statement

2021-04-09 17:36:46

BIO-IFPMA Comment on COVAX No-Fault Compensation Program for COVAX Advance Market Commitment Eligible Economies

Geneva, 9 April 2021 – We commend COVAX on the launch of its Web Portal for the no-fault compensation program ...

Read More

2021-03-30 18:20:03

COVID-19 vaccine and treatment innovators response to global leaders urgent call for international pandemic treaty

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-02-05 15:11:21

Call to Heads of State of the African Union to Ratify the African Medicines Agency Treaty

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-01-29 20:47:55

IFPMA Statement on EU COVID-19 Vaccines Supply

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-01-20 11:00:22

IFPMA, GSCF, ICBA Joint Statement on the item 14.2 Strengthening preparedness for health emergencies: implementation of the IHR @EB148

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-01-19 08:25:31

IFPMA Statement for EB148 agenda item 14.1 Covid-19 Response

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-01-13 08:17:19

Innovative biopharmaceutical industry comment on COVID-19 vaccines dosing strategies and recommend following the science

The first edition of the “Africa Young Innovators for Health ...

Read More

mailto:a.jones@ifpma.org

Abigail Jones - Director, Communications

Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.

mailto:m.depol@ifpma.org
Twitter @MorganePol

Morgane De Pol - Deputy Director, Communications

Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

News Release

meeting-discusses-covid-19-vaccine-manufacturing-bottlenecks-that-must-be-urgently-tackled-for-c19-vaccine-output-to-reach-its-full-potential

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential

9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of

Read More

Our Blog

Latest Tweets

Global Health Matters is a column on #GlobalHealth where we discuss topics ranging from sustainable health policies… https://t.co/1cpoxvQjc5
Killing almost 4,000 people every day, #TB is an “age-old monster” demanding a strong approach as the global respon… https://t.co/QPaCcnBIfj
RT @FIP_org: We’re proud to support #TeamVaccines and share the stories of the real people working hard behind the scenes on #COVID19 vacci…
1
IFPMA DG @ThomasCueni talks #COVID19 vaccines patenting and the role #innovation and collaboration had in achieving… https://t.co/DP3K5D5blP
2
My husband & son are #doctors risking their lives. I want them, their colleagues and patients to be safe from… https://t.co/Tz108NS9zk
1 2